Literature DB >> 15322936

Cost-savings achieved by eradication of epidemic methicillin-resistant Staphylococcus aureus (EMRSA)-16 from a large teaching hospital.

I Björholt1, E Haglind.   

Abstract

Methicillin-resistant Staphylococcus aureus continues to be an increasing problem worldwide, although its prevalence in the Nordic countries still is low. In 1997 an unusually readily transmissible strain of epidemic methicillin-resistant S. aureus, EMRSA-16, was introduced by a single patient into a 2,600 bed teaching hospital in Sweden. Despite the standard "search and destroy" policy (Standard MRSA Control Programme), the outbreak took on epidemic proportions. Therefore, the hospital management chose to implement vigorous and costly actions (Intensive MRSA Control Programme). These measures were successful, and the strain was completely eradicated. Whether the actions taken were cost-effective was analysed using an analytical framework in which different scenarios were simulated (decision analytic modelling). Thus, the relative costs and consequences of the Standard MRSA Control Programme and the Intensive MRSA Control Programme could be compared in a simple manner. Coefficients were developed from the observations of the transmission of the bacteria during the period preceding the study period. These were then used to simulate the outcome of the alternative programmes. The uncertainty of the results was explored in sensitivity analyses. The Intensive MRSA Control Programme was shown to be cost saving after slightly more than 24 months of implementation. In conclusion, due to vigorous control efforts, a large EMRSA-16 outbreak in a university hospital was stopped. The initial costs of the control programme were high, but future healthcare resources were saved. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Year:  2004        PMID: 15322936     DOI: 10.1007/s10096-004-1198-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  27 in total

Review 1.  Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application.

Authors:  M Sculpher; E Fenwick; K Claxton
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

2.  EMRSA-16: a new epidemic strain of Staphylococcus aureus.

Authors: 
Journal:  Commun Dis Rep CDR Wkly       Date:  1993-02-05

Review 3.  Primer on medical decision analysis: Part 1--Getting started.

Authors:  A S Detsky; G Naglie; M D Krahn; D Naimark; D A Redelmeier
Journal:  Med Decis Making       Date:  1997 Apr-Jun       Impact factor: 2.583

4.  The Nottingham Staphylococcus aureus population study: prevalence of MRSA among the elderly in a university hospital.

Authors:  S Hori; R Sunley; A Tami; H Grundmann
Journal:  J Hosp Infect       Date:  2002-01       Impact factor: 3.926

Review 5.  Epidemiology of staphylococcal infections--a European perspective.

Authors:  C Vandenbroucke-Grauls
Journal:  J Chemother       Date:  1994-04       Impact factor: 1.714

6.  Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective?

Authors:  G Papia; M Louie; A Tralla; C Johnson; V Collins; A E Simor
Journal:  Infect Control Hosp Epidemiol       Date:  1999-07       Impact factor: 3.254

7.  Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit.

Authors:  C Chaix; I Durand-Zaleski; C Alberti; C Brun-Buisson
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

8.  A national survey of antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals.

Authors:  J Turnidge; P Lawson; R Munro; R Benn
Journal:  Med J Aust       Date:  1989-01-16       Impact factor: 7.738

9.  Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991.

Authors:  A L Panlilio; D H Culver; R P Gaynes; S Banerjee; T S Henderson; J S Tolson; W J Martone
Journal:  Infect Control Hosp Epidemiol       Date:  1992-10       Impact factor: 3.254

10.  New threats to the control of methicillin-resistant Staphylococcus aureus.

Authors:  M W Casewell
Journal:  J Hosp Infect       Date:  1995-06       Impact factor: 3.926

View more
  9 in total

1.  Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing.

Authors:  M C J Bootsma; O Diekmann; M J M Bonten
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-24       Impact factor: 11.205

2.  Surveillance of microbial resistance in European Intensive Care Units: a first report from the Care-ICU programme for improved infection control.

Authors:  Håkan Hanberger; Dilek Arman; Hans Gill; Vlastimil Jindrák; Smilja Kalenic; Andrea Kurcz; Monica Licker; Paul Naaber; Elizabeth A Scicluna; Václav Vanis; Sten M Walther
Journal:  Intensive Care Med       Date:  2008-08-01       Impact factor: 17.440

Review 3.  Fighting antibiotic resistance in Sweden--past, present and future.

Authors:  Johan Struwe
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

4.  Epidemiology and control of meticillin-resistant Staphylococcus aureus in Stockholm County, Sweden, 2000 to 2016: overview of a "search-and-contain" strategy.

Authors:  Björn K G Eriksson; Ulla-Britt Thollström; Joanna Nederby-Öhd; Åke Örtqvist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-03       Impact factor: 3.267

5.  Quantifying cost-effectiveness of controlling nosocomial spread of antibiotic-resistant bacteria: the case of MRSA.

Authors:  Marjan W M Wassenberg; G Ardine de Wit; Ben A van Hout; Marc J M Bonten
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

6.  Cost-Analysis of Seven Nosocomial Outbreaks in an Academic Hospital.

Authors:  Jan-Willem H Dik; Ariane G Dinkelacker; Pepijn Vemer; Jerome R Lo-Ten-Foe; Mariëtte Lokate; Bhanu Sinha; Alex W Friedrich; Maarten J Postma
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

7.  Nationwide trends in molecular epidemiology of methicillin-resistant Staphylococcus aureus, Finland, 1997-2004.

Authors:  Anne-Marie Kerttula; Outi Lyytikäinen; Minna Kardén-Lilja; Salha Ibrahem; Saara Salmenlinna; Anni Virolainen; Jaana Vuopio-Varkila
Journal:  BMC Infect Dis       Date:  2007-08-14       Impact factor: 3.090

8.  Review of a two-year methicillin-resistant Staphylococcus aureus screening program and cost-effectiveness analysis in Singapore.

Authors:  Mar-Kyaw Win; Tarek Abdellatif Aly Soliman; Linda Kay Lee; Chia Siong Wong; Angela Chow; Brenda Ang; Carrasco L Roman; Yee-Sin Leo
Journal:  BMC Infect Dis       Date:  2015-09-29       Impact factor: 3.090

9.  Methicillin-resistant Staphylococcus aureus in Saarland, Germany: a statewide admission prevalence screening study.

Authors:  Mathias Herrmann; Christine Petit; Alik Dawson; Judith Biechele; Alexander Halfmann; Lutz von Müller; Stefan Gräber; Stefan Wagenpfeil; Renate Klein; Barbara Gärtner
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.